Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

195 projects found matching your search criteria :

  1. New post-treatment strategy against stroke and perinatal asphyxia – a novel approach based on a selective activation of ...

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Agnieszka Wnuk

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  2. Role of the NLRP3 inflammasome in the mechanisms of action of antidepressant drugs - study in an animal model of depress...

    Call: PRELUDIUM 9 , Panel: NZ7

    Principal investigator: dr Ewa Izabela Trojan

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  3. Changes in neurogenesis during withdrawal from nicotine self-administration in rats - role of serotonin (5-HT)2C recepto...

    Call: OPUS 9 , Panel: NZ4

    Principal investigator: dr Magdalena Joanna Zaniewska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  4. Wpływ wybranych chemokin na właściwości komórek nerwowych i przekaźnictwo synaptyczne w obszarze kompleksu ciała migdało...

    Call: ETIUDA 7 , Panel: NZ4

    Principal investigator: Joanna Ewa Sowa

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  5. The study of the role of mGluR8 in cancer cells - a potential target for new antitumor strategies

    Call: OPUS 3 , Panel: NZ3

    Principal investigator: dr Danuta Jantas

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  6. The group III metabotropic glutamate receptors as a target for future antypsychotic drugs

    Call: MAESTRO 3 , Panel: NZ7

    Principal investigator: prof. Andrzej Pilc

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  7. "Epigenetic mechanisms underlying cocaine seeking and relapse"

    Call: MAESTRO 3 , Panel: NZ3

    Principal investigator: prof. Małgorzata Maria Filip

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  8. PHARMACOTHERAPY OF OSTEOARTHRITIS: TRPV1 AND CB1 RECEPTORS AND THEIR ENDOGENOUS LIGANDS AS NEW TARGETS FOR PHARMACOLOGIC...

    Call: SONATA BIS 2 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Maria Starowicz-Bubak

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  9. Neurobiology of optimism; Characterisation of the neuroanatomical and neurochemical substrates of cognitive judgement bi...

    Call: SONATA BIS 2 , Panel: NZ4

    Principal investigator: dr hab. Rafał Ryguła

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  10. The research of molecular markers for neuroprotective effect of tetrahydroisoquinolines based on various eksperimental m...

    Call: OPUS 4 , Panel: NZ7

    Principal investigator: dr Agnieszka Wąsik

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  11. The effects of positive allosteric modulators of alpha7 nicotinic acetylcholine receptors on complex cognitive processes...

    Call: OPUS 4 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Anna Nikiforuk

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  12. The effect of imipramine and risperidone on regulation of the chronic mild stress-induced anhedonia and memory impairmen...

    Call: OPUS 5 , Panel: NZ7

    Principal investigator: Mariusz Papp

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  13. Motor thalamic nuclei as a potential therapeutic target for adenosine in parkinsonian and essential tremor; behavioural,...

    Call: OPUS 6 , Panel: NZ4

    Principal investigator: dr hab. Jadwiga Wardas

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  14. The effect of the novel atypical neuroleptics on the activity and expression of cytochrome P450 isoforms in human liver

    Call: OPUS 6 , Panel: NZ7

    Principal investigator: dr hab. Jacek Wójcikowski

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  15. Research of mechanisms of antidepressant action of group II and III mGlu receptor ligands and their role in inducing rap...

    Call: OPUS 7 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Pałucha-Poniewiera

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  16. Evaluation of the role of transcription factor CREB in the mechanisms antidepressant treatment: study on the novel genet...

    Call: OPUS 7 , Panel: NZ7

    Principal investigator: dr Grzegorz Kreiner

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  17. The impact of maternal diabetes on inflammasome NLRP3 activation in the offspring brain

    Call: PRELUDIUM 7 , Panel: NZ7

    Principal investigator: dr Katarzyna Elżbieta Głombik

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  18. The effect of social stress during adolescence on the psychotic symptoms development and epigenetic mechanisms in the ne...

    Call: OPUS 7 , Panel: NZ4

    Principal investigator: dr hab. Marzena Małgorzata Maćkowiak

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  19. Fluorine substitution – a new algorithm for increasing biological activity

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Wojciech Pietruś

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  20. Prenatal exposure to glucocorticoids as a risk factor for depression - the importance of epigenetic mechanisms in the br...

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: dr Katarzyna Elżbieta Głombik

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  21. The effect of omega-3 fatty acid-enriched diet on the myelination impairment and the depression-like phenotype induced b...

    Call: SONATA 16 , Panel: NZ5

    Principal investigator: dr Irena Maria Smaga-Maślanka

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  22. Novel hope for diseased joints: a polymer-based treatment to promoteregenerative strategies for patients with osteoarthr...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Marta Kędziora

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  23. The evaluation of therapeutic potential of β-caryophyllene in animal schizophrenia model - behavioral and molecular stud...

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: dr Magdalena Białoń

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  24. The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic ...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: dr Katarzyna Anna Szczepańska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  25. Early-life programming for neurodevelopmental disorders: search for a prodrome target within the vascular network in a r...

    Call: OPUS 23 , Panel: NZ4

    Principal investigator: prof. Małgorzata Maria Filip

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  26. "I like to move it, move it" – molecular dynamics-driven optimization of ligand residence time as an opportunity to impr...

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: dr hab. Sabina Marta Podlewska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  27. Semaglutide and neurodevelopment: investigating risks arising from prenatal exposure to a widely popular drug for diabet...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Agnieszka Wnuk

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  28. Modeling Progression of α-Synucleinopathy in Noradrenergic and Serotonergic Systems – Possible Link with Prodromal Sympt...

    Call: PRELUDIUM 23 , Panel: NZ4

    Principal investigator: Anna Hajam Alwani

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  29. Mechanisms of Antidepressant Action of Psilocybin: The Role of 5-HT2B-5-HT1A Receptor Dimerization and GSK-3β Activation...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr hab. Agata Faron-Górecka

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  30. Effects of ketamine optical isomers on motivation and decision-making in rats using deep learning for behavioral analysi...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Natalia Alicja Malikowska-Racia

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  31. Modulation of 5-HT7 receptor signaling as common mechanism involved in the long-lasting antidepressant effects of typica...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Barbara Wanda Chruścicka-Smaga

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  32. Reinforcement sensitivity phenotypes as determinants of various motivational styles of alcohol drinking: craving for rew...

    Call: OPUS 28 , Panel: HS6

    Principal investigator: prof. Rafał Ryguła

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  33. The role of selected signaling pathways in zinc deficiency

    Call: OPUS 10 , Panel: NZ4

    Principal investigator: prof. Gabriel Piotr Nowak

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  34. Neurodevelopmental patomechanisms of triclocarban- and dichlorodiphenyldichloroetylene-induced effects: the role of apop...

    Call: OPUS 10 , Panel: NZ7

    Principal investigator: dr hab. Małgorzata Kajta

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  35. Molecular characteristics of stress-resilient phenotype using mice models.

    Call: OPUS 12 , Panel: NZ4

    Principal investigator: prof. Marta Dziedzicka-Wasylewska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  36. Evaluation of the influence of progressive noradrenergic neurodegeneration on dopaminergic system functioning in context...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: dr Grzegorz Kreiner

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  37. Zinc Deficiency: An essential Variable for the Induction od Resistance to Antidepressants

    Call: PRELUDIUM 13 , Panel: NZ5

    Principal investigator: dr Anna Maria Rafało-Ulińska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  38. Contribution of nitrergic transmission in the modulation of L-dopa activity in the rat 6-OHDA model of Parkinson's disea...

    Call: OPUS 1 , Panel: NZ4

    Principal investigator: dr hab. Elżbieta Kazimiera Lorenc-Koci

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  39. Opioid receptors in the basal ganglia of the brain as targets for alcohol abuse therapy.

    Call: OPUS 2 , Panel: NZ4

    Principal investigator: dr Jan Manuel Rodriguez Parkitna

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  40. Modified maternal diet as a factor of autism spectrum disorders in offspring - preclinical molecular studies on prefront...

    Call: PRELUDIUM 15 , Panel: NZ7

    Principal investigator: Kinga Eryka Gawlińska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  41. Searching for effective strategies to protect neuronal cells against hypoxia and ischemia: Identification of neuroprotec...

    Call: OPUS 16 , Panel: NZ7

    Principal investigator: prof. Małgorzata Kajta

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  42. The role of nitric oxide-dependent pathways in the procognitive effects of muscarinic and metabotropic glutamate recepto...

    Call: OPUS 17 , Panel: NZ7

    Principal investigator: dr hab. Joanna Monika Wierońska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  43. Znaczenie interakcji układu endokanabinoidowego i endowaniloidowego w leczeniu bólu przewlekłego - potencjał terapeutycz...

    Call: ETIUDA 3 , Panel: NZ7

    Principal investigator: Natalia Eleonora Małek

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  44. Altered interaction between NMDA receptor subunits and their scaffolding proteins as a critical step to control drug see...

    Call: OPUS 9 , Panel: NZ7

    Principal investigator: prof. Małgorzata Maria Filip

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  45. Simultaneous stimulation of muscarinic M4 receptor and selected receptors involved in the regulation of glutamate releas...

    Call: OPUS 9 , Panel: NZ7

    Principal investigator: dr hab. Joanna Monika Wierońska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  46. Exploring new drug targets for efficacious therapy of neuropathic pain basing on the assessment and modulation of neuroi...

    Call: OPUS 2 , Panel: NZ4

    Principal investigator: dr hab. Joanna Gabriela Mika

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  47. Pharmacological evaluation of possible neuroprotective strategies in novel genetic mouse models of progressive neurodege...

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: dr Grzegorz Kreiner

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  48. The role of glucocorticoids in the regulaton of neurodegenerative prosses

    Call: PRELUDIUM 3 , Panel: NZ7

    Principal investigator: Anna Jadwiga Kurek

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  49. The role of CRH-BP protein in the regulation of the hypothalamic-pituitary-adrenal axis after antidepressant drugs treat...

    Call: OPUS 3 , Panel: NZ4

    Principal investigator: dr Joanna Solich

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  50. Effect of paroxetine and risperidone on the heterodimerization of dopamine D2 and serotonin 5-HT1A receptor in the conte...

    Call: PRELUDIUM 3 , Panel: NZ7

    Principal investigator: dr Magdalena Anna Kolasa

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk